5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer

This publication has 13 references indexed in Scilit:

• Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.
  Journal of Clinical Oncology, 1998
• Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
  Journal of Clinical Oncology, 1996
• Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy.
  Journal of Clinical Oncology, 1994
• Lack of effect of interferon α2a upon fluorouracil pharmacokinetics
  British Journal of Cancer, 1994
• Marked Fluctuations in Drug Plasma Concentrations Caused by Use of Portable Pumps for Fluorouracil Continuous Infusion
  JNCI Journal of the National Cancer Institute, 1993
• Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.
  1992
• Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome
  Cancer, 1991
• RELATIONSHIP BETWEEN DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY AND PLASMA 5-FLUOROURACIL LEVELS WITH EVIDENCE FOR CIRCADIAN VARIATION OF ENZYME-ACTIVITY AND PLASMA DRUG LEVELS IN CANCER-PATIENTS RECEIVING 5-FLUOROURACIL BY PROTRACTED CONTINUOUS INFUSION
  1990
• A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
  Journal of Clinical Oncology, 1989
• 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer
  British Journal of Cancer, 1989